SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Market Cap	4.57B
Revenue (ttm)	1.26B
Net Income (ttm)	393.28M
Shares Out	44.59M
EPS (ttm)	8.80
PE Ratio	11.65
Forward PE	n/a
Dividend	5.30 (5.30%)
Ex-Dividend Date	Jul 19, 2024

Volume	87,026
Average Volume	261,043
Open	102.50
Previous Close	102.50
Day's Range	101.50 - 102.50
52-Week Range	81.70 - 110.00
Beta	0.00
RSI	49.99
Earnings Date	Mar 7, 2025

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, antihypertensive, α- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anest...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 227
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2024, SYN-TECH Chem. & Pharm.'s revenue was 1.26 billion, an increase of 12.83% compared to the previous year's 1.11 billion. Earnings were 393.28 million, an increase of 56.68%.